Northrop Grumman Q1 2026: Earnings Surge, B-21 Risk Remains
Northrop Grumman's Q1 2026 net income jumped 82%, but the surge masks unresolved B-21 fixed-price risk. Full NOC 2026-Q1 earnings breakdown.
Northrop Grumman (NOC) reported an 82% jump in net income for the first quarter of 2026, a figure that demands immediate context: the surge is driven almost entirely by the absence of a $477 million loss provision on the B-21 Raider program that depressed results in the same quarter a year ago. The company's 10-Q, filed April 21, 2026, reveals a defense prime operating in a historically favorable budget environment while simultaneously managing unresolved fixed-price execution risk on its most consequential program.
The Headline Numbers
Net income rose from $481 million in Q1 2025 to $875 million in Q1 2026, an 82% increase. Diluted earnings per share climbed 85% over the same period, with a roughly 2% reduction in diluted share count — the result of an active buyback program — amplifying the per-share gain. Operating income moved from $573 million to $989 million, a 73% improvement, and overall operating margin expanded from 6.1% to 10.0% in a single year.
Total sales increased $413 million, or 4% year-over-year, to $9.88 billion for the quarter. That is a meaningful but measured top-line advance. The dramatic widening of the earnings line relative to revenue growth is the central analytical question the filing raises — and the answer lies almost entirely in one prior-year item.
What Changed: The B-21 Comparison and Segment Performance
The MD&A is direct on causality. In Q1 2025, NOC recorded a $477 million loss provision on the B-21 Raider Low-Rate Initial Production (LRIP) program. That charge did not repeat in Q1 2026. Strip that single item from the prior-year results and the year-over-year improvement, while still real, is substantially more modest than the headline suggests. Management acknowledges that cumulative LRIP losses on the B-21 have now exceeded $2 billion, and states explicitly that results "could be materially affected" if cost estimates change — language the filing's context renders substantive rather than boilerplate.
Aeronautics Systems led all segments with revenue growth of $469 million, or 17%, driven by a new agreement with the U.S. Air Force to expand B-21 production capacity and the sale of a company-owned test asset. The latter is a one-time transaction, not a recurring revenue source. Segment operating margin comparisons are favorable almost by construction given the prior-year loss provision.
Mission Systems was the quarter's quiet outperformer. Operating margin expanded from 12.9% to 15.1%, a 220-basis-point improvement with no analogous prior-year charge to explain it. That is genuine operational progress, and 15.1% sits at the high end of what mission systems businesses typically generate in this industry.
Space Systems moved in the opposite direction. Operating margin declined from 11.0% to 9.5%, driven by a $71 million unfavorable Estimate at Completion (EAC) adjustment on the GEM 63XL program following a launch anomaly, compounded by approximately $98 million in revenue lost to the wind-down of the Next Generation Interceptor (NGI) program. The Space Development Agency satellite program is ramping as a partial offset, but the net segment result was negative this quarter. The filing does not quantify downstream contract implications from the launch anomaly.
Defense Systems results are not directly comparable to the prior year because the training services business was divested in May 2025. Management notes that 2025 operating results include sales and operating income for that business prior to the divestiture date.
Total backlog at quarter-end was $95.6 billion. Net new awards for the quarter were $9.8 billion, including $4.9 billion for restricted programs. With quarterly revenue also at $9.88 billion, the book-to-bill ratio for the period was essentially 1.0 — meaning orders are keeping pace with deliveries, but backlog is not yet growing in absolute terms.
Balance Sheet and Liquidity
Cash and equivalents grew 24% year-over-year, from $1.69 billion to $2.09 billion. Stockholders' equity increased 14% over the same period, from approximately $15 billion to $17.1 billion. These are genuine balance sheet improvements.
Long-term debt stands at $14.41 billion, producing a net debt position of roughly $12.3 billion after cash. NOC also has a $3 billion revolving credit facility available, bringing total accessible liquidity to approximately $5 billion. For a company generating operating income at the current run rate, that structure is manageable — but it is not a light balance sheet, and it leaves limited margin for sustained earnings pressure.
The capital allocation picture is complicated by a significant new commitment. The filing discloses that NOC expects to invest approximately $2.5 billion over a multi-year period to expand B-21 production capacity, in exchange for the opportunity to earn improved returns on the LRIP and NTE phases of the program. The word "opportunity" in that formulation is precise: improved returns are contingent on execution, not guaranteed. This is a large capital bet on a program whose near-term economics are still generating losses, made against a balance sheet that is already carrying substantial leverage.
Risks and Disclosures
The B-21 remains the dominant risk disclosure. Management states that Q1 2026 results "reflect our current best estimate of cost to complete the LRIP and NTE aircraft, as well as the outcome of ongoing discussions with our suppliers." The phrase "ongoing discussions with our suppliers" signals that the cost picture on this program is not closed. Any adverse movement in those negotiations or in internal cost estimates could trigger another EAC adjustment and another loss provision.
The Sentinel ICBM modernization program also carries forward-looking risk. The filing notes that no significant cost estimate changes were made in Q1 2026, but the restructure is ongoing and the Production and Deployment phases have not yet been priced or negotiated. Those are unquantified future exposures.
On the budget environment, NOC cites the One Big Beautiful Bill Act, enacted July 4, 2025, which allocates approximately $150 billion in mandatory defense funding with appropriated funds available to be obligated through September 2029 and expended through fiscal year 2034. FY 2026 defense appropriations totaled approximately $859 billion. Management describes the global security environment as a structural demand driver, citing needs in space, C4ISR, air and missile defense, strategic deterrence, and autonomous aircraft systems.
That positive backdrop coexists with acknowledged uncertainty. The filing states that "issues related to budgetary priorities, defense spending levels and the debt ceiling will continue to be subjects of considerable debate, with a potentially significant impact on our programs and the company." Management also flags that executive orders on defense acquisition reform "could adversely affect our business or create a more challenging or costly regulatory, operating and economic environment."
On tariffs, the filing references a U.S. Supreme Court decision that invalidated tariffs imposed under the International Emergency Economic Powers Act, and notes that tariffs have subsequently been imposed under different statutory authorities, including a 10% global tariff. Management states it does not believe tariffs have had or will have a material adverse effect on its business, while acknowledging that the full impact is "uncertain, difficult to predict." A partial government shutdown affecting the Department of Homeland Security was ongoing as of the filing date; management does not expect it to materially affect NOC given that DHS is not a primary customer.
What to Watch
The next B-21 EAC review is the single most consequential near-term data point. If supplier negotiations resolve favorably and cost estimates hold, the fixed-price execution risk embedded in this filing is contained and the earnings improvement is more durable. If estimates deteriorate again, the operating income line is vulnerable to a reversal of the magnitude seen in Q1 2025. Beyond B-21, the pace at which OBBBA-funded program starts translate into new awards will determine whether book-to-bill moves sustainably above 1.0 — the threshold at which backlog begins growing rather than holding. The Space Systems segment's trajectory following the GEM 63XL launch anomaly, and the eventual pricing of Sentinel's Production and Deployment phases, round out the forward agenda this filing leaves open.